Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PDS Biotechnology Corporation - Common Stock (NQ:PDSB)

1.270 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.270
Bid (Size) 1.210 (11)
Ask (Size) 1.380 (1)
Prev. Close 1.270
Today's Range 1.270 - 1.270
52wk Range 0.8505 - 4.420
Shares Outstanding 28,458,688
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
PDS Biotechnology Stock In Spotlight On Better-Than-Feared 2024 Loss – Retail Stays Bearish
The company said the reduced losses were primarily due to decreased operating expenses. 
Via Stocktwits

Performance

YTD
-26.6%
-26.6%
1 Month
-25.7%
-25.7%
3 Month
+35.8%
+35.8%
6 Month
-24.4%
-24.4%
1 Year
-60.7%
-60.7%

More News

Read More
A Look at PDS Biotechnology's Upcoming Earnings Report
Via Benzinga
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Uncovering Potential: PDS Biotechnology's Earnings Preview
Via Benzinga
Earnings Preview For PDS Biotechnology
Via Benzinga
Earnings Scheduled For May 14, 2025
Via Benzinga
Insights Ahead: PDS Biotechnology's Quarterly Earnings
Via Benzinga
Earnings Scheduled For March 27, 2025
Via Benzinga
Life Sciences Investor Forum Agenda Announced for March 13th
From Virtual Investor Conferences
Via GlobeNewswire
Analyst Expectations for PDS Biotechnology's Future
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024
Via InvestorPlace
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q4 2023
Via InvestorPlace
PDS Biotechnology: Q3 Earnings Insights
Via Benzinga
A Preview Of PDS Biotechnology's Earnings
Via Benzinga
The Latest Analyst Ratings for PDS Biotechnology
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 27, 2024
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Scheduled For August 14, 2023
Via Benzinga

Frequently Asked Questions

Is PDS Biotechnology Corporation - Common Stock publicly traded?
Yes, PDS Biotechnology Corporation - Common Stock is publicly traded.
What exchange does PDS Biotechnology Corporation - Common Stock trade on?
PDS Biotechnology Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PDS Biotechnology Corporation - Common Stock?
The ticker symbol for PDS Biotechnology Corporation - Common Stock is PDSB on the Nasdaq Stock Market
What is the current price of PDS Biotechnology Corporation - Common Stock?
The current price of PDS Biotechnology Corporation - Common Stock is 1.270
When was PDS Biotechnology Corporation - Common Stock last traded?
The last trade of PDS Biotechnology Corporation - Common Stock was at 07/08/25 04:00 PM ET
What is the market capitalization of PDS Biotechnology Corporation - Common Stock?
The market capitalization of PDS Biotechnology Corporation - Common Stock is 36.14M
How many shares of PDS Biotechnology Corporation - Common Stock are outstanding?
PDS Biotechnology Corporation - Common Stock has 36M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.